Citation Impact
Citing Papers
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
2011
Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
2012
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Synovitis in osteoarthritis: current understanding with therapeutic implications
2017 Standout
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
2010
Methodology in conducting a systematic review of systematic reviews of healthcare interventions
2011 Standout
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
The Pathogenesis of Lupus Nephritis
2013
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
2010
Rheumatoid arthritis
2018 Standout
New therapies for treatment of rheumatoid arthritis
2007
Rheumatoid arthritis
2016 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
CD28 Costimulation: From Mechanism to Therapy
2016
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
2009
The problem of choice: current biologic agents and future prospects in RA
2013
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
2017
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
2016
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
2012
Biologics and heart failure in rheumatoid arthritis: are we any wiser?
2008
Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
2013
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family
2011
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review
2011
IL-6 as a keystone cytokine in health and disease
2015 Standout
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
2012
Forget personalised medicine and focus on abating disease activity
2012
Therapeutic antibodies for autoimmunity and inflammation
2010
Antibody therapy of cancer
2012 Standout
SGLT inhibitors in management of diabetes
2013
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
2009
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Use of abatacept in rheumatoid arthritis
2012
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches
2018
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis
2019
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Type 2 diabetes
2017 Standout
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
2009
Systemic Lupus Erythematosus
2011 Standout
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
2008
Abatacept: A Novel Treatment for Moderate‐to‐Severe Rheumatoid Arthritis
2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Newer Biological Agents in Rheumatoid Arthritis
2010
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Abatacept therapy and safety management
2009
Rheumatoid arthritis
2010 Standout
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
2017 Standout
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
2015
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
2016
Systemic lupus erythematosus
2014
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
2009
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
Ulcerative colitis
2020 Standout
Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
2015
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
2010
Clinical targeting of the TNF and TNFR superfamilies
2013
The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
2010
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study
2016
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Alternative molecular formats and therapeutic applications for bispecific antibodies
2015
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
Actinomyces and Related Organisms in Human Infections
2015 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis.
2008
Anti-TNF Therapy
2016
Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis
2014
Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis
2010
Novel TNF antagonists for the treatment of rheumatoid arthritis
2009
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Etanercept for the treatment of rheumatoid arthritis
2013
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Drugs for discoid lupus erythematosus
2017
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
2020
Etanercept for the Treatment of Rheumatoid Arthritis
2018
Explainable Artificial Intelligence (XAI): What we know and what is left to attain Trustworthy Artificial Intelligence
2023 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
2017
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
2012 StandoutNobel
Industry sponsorship and research outcome
2017 Standout
Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
2012
Generic quality-of-life assessment in rheumatoid arthritis.
2007
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway
2016
Works of T. Li being referenced
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
2006
The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial
2010
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
2007
A clinically meaningful difference was generated for a performance measure of recovery from hip fracture
2004
Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept
2008
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium–glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects
2010